Michèle Barzach
Corporate Officer/Principal en International AIDS Vaccine Initiative, Inc. .
Cargos activos de Michèle Barzach
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Corporate Officer/Principal | 30/11/2010 | - |
Historial de carrera de Michèle Barzach
Antiguos cargos conocidos de Michèle Barzach.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| GSK PLC | Director/Miembro de la Junta | 01/01/1997 | 17/05/2004 |
| Independent Dir/Board Member | 01/01/1997 | 17/05/2004 |
Estadísticas
Internacional
| Reino Unido | 2 |
| Estados Unidos | 2 |
Operativa
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| GSK PLC | Health Technology |
| Empresas privadas | 1 |
|---|---|
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Michèle Barzach
- Experiencia
